Table 2.

Adverse Cardiovascular Outcomes Among Individuals Older than 65 Years Who Are Exposed and Unexposed to Amphetamines

Before propensity score matchingAfter propensity score matching
OutcomesOverall Risk n/N (%)Odds Ratio (CI)P valueOverall Risk n/N (%)Odds Ratio (CI)P value
Cardiovascular Event
    Amphetamine191/4966 (3.85)7.07 (5.12, 9.76)<.01191/4966 (3.85)6.16 (4.22, 8.99)<.01
    Non-Amphetamine45/8267 (0.54)31/4966 (0.62)
Heart failure
    Amphetamine35/4966 (0.7)5.83 (2.89, 11.76)<.0135/4966 (0.7)3.5 (1.74, 7.06)<.01
    Non-Amphetamine10/8267 (0.12)10/4966 (0.2)
Stroke
    Amphetamine25/4966 (0.5)4.16 (2.0, 8.66)<.0125/4966 (0.5)2.5 (1.2, 5.2).01
    Non-Amphetamine10/8266 (0.1210/4966 (0.2)
Myocardial infarction
    Amphetamine10/4966 (0.2)1.66 (0.69, 4.0).2510/4966 (0.2)1.0 (0.42, 2.4)1.0
    Non-Amphetamine10/8267 (0.12)10/4966 (0.2)
Ischemic heart disease
    Amphetamine78/4966 (1.57)8.12 (4.74, 13.88)<.0178/4966 (1.57)7.09 (3.78, 13.31)<.01
    Non-Amphetamine16/8267 (0.19)11/4966 (0.22)
Arrhythmias
    Amphetamine69/4966 (1.39)7.66 (4.39, 13.37)<.0169/4966 (1.39)6.9 (3.56, 13.38)<.01
    Non-Amphetamine15/8267 (0.18)10/4966 (0.2)
Atrial fibrillation
    Amphetamine44/4966 (0.89)7.32 (3.69, 14.54)<.0144/4966 (0.89)4.4 (2.22, 8.73)<.01
    Non-Amphetamine10/8267 (0.12)10/4966 (0.2)
  • CI, confidence interval.